A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors
Ontology highlight
ABSTRACT: The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. The main questions it aims to answer are:
1. what is the maximum tolerated dose and recommended dose for phase 2?
2. how safe and tolerable is TOS-358 at different dose levels when taken orally once or twice per day?
DISEASE(S): Ovarian Cancer,Endometrial Cancer,Her2-negative Breast Cancer,Squamous Cell Carcinoma Of Head And Neck,Carcinoma,Cervical Cancer,Colorectal Cancer,Gastric Cancer,Non-small Cell Lung Cancer,Urothelial Carcinoma,Endometrial Neoplasms
PROVIDER: 4906 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA